Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-02-12, Stock:LLY, The news for the past five days is as follows:
2020-02-05: NEWS1: Top Research Reports for Netflix, Eli Lilly & United Parcel Service.NEWS2: Here Are 4 Leading Pharmaceutical Stocks To Consider In Early 2020.NEWS3: Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?.
2020-02-06: NEWS1: Sanofi (SNY) Q4 Earnings Top, Sales Miss, Dupixent Strong.NEWS2: The Zacks Analyst Blog Highlights: Netflix, Eli Lilly, United Parcel Service, Microsoft and Nike.
2020-02-07: NEWS1: Lilly to Participate in Guggenheim Healthcare Talks Idea Forum.NEWS2: Teva (TEVA) to Report Q4 Earnings: What's in the Cards?.NEWS3: The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns.
2020-02-10: NEWS1: US STOCKS-S&P 500, Nasdaq reach record closing highs; Chinese workers return.NEWS2: US STOCKS-Nasdaq hits new high as investors look beyond coronavirus.NEWS3: Pharma Giant Slides On Alzheimer's Failure — Taking Biogen With It.NEWS4: US STOCKS-Wall Street higher on U.S. growth optimism; Nasdaq hits record.NEWS5: Eli Lilly Suffers Setback As Alzheimer's Study Fails To Meet Primary Endpoint.NEWS6: Pharma Giants Slide On Alzheimer's Failures — Taking Biogen With Them.NEWS7: US STOCKS-Wall St steady as investors weigh coronavirus risks.NEWS8: Roche, Lilly drugs fail to halt gene-driven Alzheimer's disease.NEWS9: Eli Lilly Shares Slide After Alzheimer's Treatment Fails Clinical Trial.NEWS10: Lilly and Biogen Stocks Get Hit as Another Alzheimer’s Treatment Fails a Trial.NEWS11: US STOCKS-Wall Street set for subdued open as investors weigh coronavirus risks.NEWS12: Lilly's stock falls on failed Alzheimer's study.NEWS13: Lilly Announces Topline Results for Solanezumab from the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Study.NEWS14: Roche and Eli Lilly drugs fail ‘inherited’ Alzheimer’s trial.
2020-02-11: NEWS1: These Pharma Giants Took A Hit On Two More Alzheimer's Failures.NEWS2: Lilly Reports Disappointing Data on Alzheimer's Candidate.

Answer: Decrease